1.
Curr Cardiol Rep
; 2(1): 56-60, 2000 Jan.
Article
in English
| MEDLINE
| ID: mdl-10980873
ABSTRACT
The use of antithrombotic agents to prevent thromboembolic events in patients with valvular heart disease is common. Recent studies using improved diagnostic techniques have allowed better elucidation of valvular abnormalities and re-evaluated the incidence and risk of thromboembolism. We review the recent literature examining the risk of thromboembolic events in various valvular abnormalities, and the use of different antithrombotic agents in the prevention of thromboembolic events. We also review the current recommended practice in both native valve abnormalities and prosthetic heart valves.
Subject(s)
Heart Valve Diseases/complications , Heart Valve Prosthesis , Stroke/prevention & control , Thrombolytic Therapy , Aortic Valve Stenosis/complications , Bioprosthesis , Endocarditis/complications , Humans , Mitral Valve Prolapse/complications , Mitral Valve Stenosis/complications , Rheumatic Heart Disease/complications , Stroke/etiology
2.
Chest
; 114(5 Suppl): 590S-601S, 1998 Nov.
Article
in English
| MEDLINE
| ID: mdl-9822065